Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707

The standard CHOP therapy for peripheral T-cell lymphoma has resulted in unsatisfactory outcomes and it is still not clear what is the optimal front-line therapy. We conducted a multicenter phase II study of dose-adjusted etoposide, doxorubicin, and cyclophosphamide with vincristine and prednisone (...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Yoshinobu, Nishimori, Hisakazu, Yoshida, Isao, Hiramatsu, Yasushi, Uno, Masatoshi, Masaki, Yasufumi, Sunami, Kazutaka, Masunari, Taro, Nawa, Yuichiro, Yamane, Hiromichi, Gomyo, Hiroshi, Takahashi, Tsutomu, Yano, Tomofumi, Matsuo, Keitaro, Ohshima, Koichi, Nakamura, Shigeo, Yoshino, Tadashi, Tanimoto, Mitsune
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709109/
https://www.ncbi.nlm.nih.gov/pubmed/28971899
http://dx.doi.org/10.3324/haematol.2017.167742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709109/
https://www.ncbi.nlm.nih.gov/pubmed/28971899
http://dx.doi.org/10.3324/haematol.2017.167742

Ejemplares similares